Halloween has come and gone in the US, and Americans are now gearing up for Thanksgiving and Christmas. But before the holiday season could get underway, the country went through a major political event with far-reaching implications: the midterm elections.As…
Japanese generic major Towa Pharmaceutical has reached a settlement with SymBio Pharmaceuticals and Eagle Pharmaceuticals in a patent infringement lawsuit filed in Japan over its version of the cancer agent Treakisym (bendamustine). SymBio, which markets Treakisym in the country, and…
To read the full story
Related Article
- Towa Set to Take on Legal Battle over Treakisym Patent
January 17, 2023
- SymBio, Eagle Take Pfizer Japan to Court after Treakisym Gx Launch
December 27, 2022
- SymBio, Eagle Pharma Sue Towa over Treakisym Patent in Japan
December 19, 2022
BUSINESS
- Nipro Eyes 50-60 Stemirac Treatment Sites across Japan after Full Nod
November 20, 2026
- AstraZeneca’s Etcamah to Hit Japan Market on Nov. 27
November 20, 2026
- Japan Drug Makers’ Sales Seen Dipping in FY2026 on Co-Marketing Exits
November 20, 2026
- J&J’s Icotyde Could Broaden Psoriasis Treatment Options: Expert
November 20, 2026
- Nippon Kayaku to Acquire AstraZeneca’s Zoladex on Dec. 16
November 20, 2026





